Have the successive ‘Drug Policies’ of India delivered? If not, why not?

January 11, 2011 edition of ‘The Lancet’ in its article titled, “Financing health care for all: challenges and opportunities” commented as follows: “India’s health financing system is a cause of and an exacerbating factor in the challenges of health inequity, … Continue reading

85% of the patented new drugs have therapeutic equivalents…they do not increase the cost of treatment for the common man: Points…Counterpoints

Affordability of patented drugs has become a major controversial and at the same time a very sensitive issue in the healthcare space of India, just as in many other parts of the world. The government, the NGOs and other stakeholders, … Continue reading

Indian Patent offices (IPOs) have started showing improvement in their functioning; still lot of grounds to cover.

Indian Patent offices are located, with four clearly specified jurisdictions, at New Delhi, Mumbai, Kolkata and Chennai. Since last few years enough efforts have been made towards overall capacity building initiatives, training of personnel and digitalizing the huge databank of … Continue reading

65% of Indians do not have access to affordable modern medical treatment – why?

India is indeed a country of many paradoxes. Not just peaceful co-existence of luxurious sky scrapers and dilapidated shanties side by side. In the healthcare sector as well, we witness on one side booming medical tourism of foreign nationals to … Continue reading